ArticleJournal for immunotherapy of cancer2020
Correction: Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.